{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:36:48Z","timestamp":1791117408745,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40272-013-0040-6","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T16:01:05Z","timestamp":1373904065000},"page":"329-334","source":"Crossref","is-referenced-by-count":24,"title":["Effects of Fetal Exposure to Maternal Chemotherapy"],"prefix":"10.1007","volume":"15","author":[{"given":"Jana","family":"Dekrem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Van Calsteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"issue":"4","key":"40_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","volume":"7","author":"NA Pavlidis","year":"2002","unstructured":"Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7(4):279\u201387.","journal-title":"Oncologist."},{"issue":"4","key":"40_CR2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/GRF.0b013e318236e781","volume":"54","author":"JR Walton","year":"2011","unstructured":"Walton JR, Prasad MR. Obstetric and neonatal outcomes of cancer treated during pregnancy. Clin Obstet Gynecol. 2011;54(4):567\u201373.","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"40_CR3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","volume":"28","author":"K Calsteren Van","year":"2010","unstructured":"Van Calsteren K, Heyns L, De Smet F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010;28(4):683\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"40_CR4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1754-9485.2009.02124.x","volume":"53","author":"SA Luis","year":"2009","unstructured":"Luis SA, Christie DR, Kaminski A, et al. Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review. J Med Imaging Radiat Oncol. 2009;53(6):559\u201368.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"3","key":"40_CR5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ygyno.2010.08.019","volume":"119","author":"K Calsteren Van","year":"2010","unstructured":"Van Calsteren K, Verbesselt R, Beijnen J, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol. 2010;119(3):594\u2013600.","journal-title":"Gynecol Oncol."},{"issue":"4","key":"40_CR6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/humupd\/7.4.394","volume":"7","author":"J Arnon","year":"2001","unstructured":"Arnon J, Meirow D, Lewis-Roness H, et al. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001;7(4):394\u2013403.","journal-title":"Hum Reprod Update."},{"issue":"5","key":"40_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","volume":"5","author":"E Cardonick","year":"2004","unstructured":"Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283\u201391.","journal-title":"Lancet Oncol."},{"issue":"2","key":"40_CR8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0163-7258(97)82004-9","volume":"74","author":"U Ebert","year":"1997","unstructured":"Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther. 1997;74(2):207\u201320.","journal-title":"Pharmacol Ther."},{"issue":"3","key":"40_CR9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.reprotox.2005.04.004","volume":"20","author":"M Santis De","year":"2005","unstructured":"De Santis M, Di Gianantoni E, Straface G, et al. Ionizing radiations in pregnancy and teratogenesis: a review of literature. Reprod Toxicol. 2005;20(3):323\u20139.","journal-title":"Reprod Toxicol."},{"issue":"5","key":"40_CR10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1470-2045(05)70169-8","volume":"6","author":"HB Kal","year":"2005","unstructured":"Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6(5):328\u201333.","journal-title":"Lancet Oncol."},{"issue":"Suppl 1","key":"40_CR11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/IGC.0b013e3181a1d0ec","volume":"19","author":"F Amant","year":"2009","unstructured":"Amant F, Van Calsteren K, Halaska MJ, et al. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer. 2009;19(Suppl 1):S1\u201312.","journal-title":"Int J Gynecol Cancer."},{"issue":"3","key":"40_CR12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/gyno.2000.6080","volume":"80","author":"RJ Isaacs","year":"2001","unstructured":"Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy: case report and literature review. Gynecol Oncol. 2001;80(3):405\u20138.","journal-title":"Gynecol Oncol."},{"issue":"9815","key":"40_CR13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(11)61092-1","volume":"379","author":"F Amant","year":"2012","unstructured":"Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy. Lancet. 2012;379(9815):570\u20139.","journal-title":"Lancet"},{"issue":"3","key":"40_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bdra.22887","volume":"94","author":"SA Rasmussen","year":"2012","unstructured":"Rasmussen SA. Human teratogens update 2011: can we ensure safety during pregnancy? Birth Defects Res A Clin Mol Teratol. 2012;94(3):123\u20138.","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"issue":"6","key":"40_CR15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eci.10.77","volume":"6","author":"HA Azim Jr","year":"2010","unstructured":"Azim HA Jr, Azim H, Peccatori FA. Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev Clin Immunol. 2010;6(6):821\u20136.","journal-title":"Expert Rev Clin Immunol."},{"issue":"1","key":"40_CR16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-012-1996-6","volume":"133","author":"HA Azim Jr","year":"2012","unstructured":"Azim HA Jr, Metzger-Filho O, de Azambuja E, et al. Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01). Breast Cancer Res Treat. 2012;133(1):387\u201391.","journal-title":"Breast Cancer Res Treat."},{"issue":"15","key":"40_CR17","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2165\/11596240-000000000-00000","volume":"71","author":"A Makol","year":"2011","unstructured":"Makol A, Wright K, Amin S. Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management. Drugs. 2011;71(15):1973\u201387.","journal-title":"Drugs."},{"issue":"8","key":"40_CR18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1470-2045(06)70797-5","volume":"7","author":"M Decker","year":"2006","unstructured":"Decker M, Rothermundt C, Hollander G, et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol. 2006;7(8):693\u20134.","journal-title":"Lancet Oncol"},{"issue":"5","key":"40_CR19","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","volume":"117","author":"EF Chakravarty","year":"2011","unstructured":"Chakravarty EF, Murray ER, Kelman A, et al. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117(5):1499\u2013506.","journal-title":"Blood."},{"issue":"5","key":"40_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.blre.2008.03.006","volume":"22","author":"T Shapira","year":"2008","unstructured":"Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev. 2008;22(5):247\u201359.","journal-title":"Blood Rev."},{"key":"40_CR21","first-page":"371","volume-title":"Acute leukemia: the scientist\u2019s perspective and challenge","author":"C Vandenbriele","year":"2011","unstructured":"Vandenbriele C, Vassou A, Pentheroudakis G, et al. Hematologic malignancies in pregnancy. In: Antica M, editor. Acute leukemia: the scientist\u2019s perspective and challenge. New York: InTech; 2011. p. 371\u201390."},{"issue":"11","key":"40_CR22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1447-0756.2011.01591.x","volume":"37","author":"RN Eskander","year":"2011","unstructured":"Eskander RN, Tarsa M, Herbst KD, et al. Chronic myelocytic leukemia in pregnancy: a case report describing successful treatment using multimodal therapy. J Obstet Gynaecol Res. 2011;37(11):1731\u20133.","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"40_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.reprotox.2011.11.003","volume":"33","author":"BP Yazdani","year":"2012","unstructured":"Yazdani BP, Matok I, Garcia BF, et al. A systematic review of the fetal safety of interferon alpha. Reprod Toxicol. 2012;33(3):265\u20138.","journal-title":"Reprod Toxicol."},{"issue":"8","key":"40_CR24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.placenta.2005.09.001","volume":"27","author":"C Gedeon","year":"2006","unstructured":"Gedeon C, Koren G. Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta. 2006;27(8):861\u20138.","journal-title":"Placenta"},{"issue":"1","key":"40_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0889-8545(05)70356-9","volume":"25","author":"M Garland","year":"1998","unstructured":"Garland M. Pharmacology of drug transfer across the placenta. Obstet Gynecol Clin N Am. 1998;25(1):21\u201342.","journal-title":"Obstet Gynecol Clin N Am."},{"issue":"8","key":"40_CR26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","volume":"43","author":"MR Syme","year":"2004","unstructured":"Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet. 2004;43(8):487\u2013514.","journal-title":"Clin Pharmacokinet."},{"issue":"3","key":"40_CR27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.reprotox.2006.01.007","volume":"22","author":"M Ceckova-Novotna","year":"2006","unstructured":"Ceckova-Novotna M, Pavek P, Staud F. P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod Toxicol. 2006;22(3):400\u201310.","journal-title":"Reprod Toxicol."},{"issue":"1","key":"40_CR28","first-page":"63","volume":"24","author":"B Gaillard","year":"1995","unstructured":"Gaillard B, Leng JJ, Grellet J, et al. Transplacental passage of epirubicin [article in French]. J Gynecol Obstet Biol Reprod (Paris). 1995;24(1):63\u20138.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"5","key":"40_CR29","first-page":"595","volume":"18","author":"P Grohard","year":"1989","unstructured":"Grohard P, Akbaraly JP, Saux MC, et al. Transplacental passage of doxorubicin [article in French]. J Gynecol Obstet Biol Reprod (Paris). 1989;18(5):595\u2013600.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"3","key":"40_CR30","first-page":"101","volume":"2","author":"L Heyns","year":"2011","unstructured":"Heyns L, Van Calsteren K, Han SN, et al. Review: chemotherapy during pregnancy. Belgian J Hematol. 2011;2(3):101\u20136.","journal-title":"Belgian J Hematol"},{"issue":"1","key":"40_CR31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1933719110379650","volume":"18","author":"K Calsteren Van","year":"2011","unstructured":"Van Calsteren K, Verbesselt R, Van Bree R, et al. Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod Sci. 2011;18(1):57\u201363.","journal-title":"Reprod Sci."},{"issue":"9","key":"40_CR32","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.1999.17.9.2971","volume":"17","author":"RJ Gralla","year":"1999","unstructured":"Gralla RJ, Osoba D, Kris MG, et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol. 1999;17(9):2971\u201394.","journal-title":"J Clin Oncol."},{"issue":"10","key":"40_CR33","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3109\/00016349.2010.512070","volume":"89","author":"K Calsteren Van","year":"2010","unstructured":"Van Calsteren K, Verbesselt R, Ottevanger N, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand. 2010;89(10):1338\u201345.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"12","key":"40_CR34","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa071453","volume":"357","author":"RJ Wapner","year":"2007","unstructured":"Wapner RJ, Sorokin Y, Mele L, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357(12):1190\u20138.","journal-title":"N Engl J Med."},{"issue":"3","key":"40_CR35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","volume":"2","author":"A Avil\u00e9s","year":"2001","unstructured":"Avil\u00e9s A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2(3):173\u20137.","journal-title":"Clin Lymphoma."},{"issue":"6","key":"40_CR36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cncr.22081","volume":"107","author":"KM Hahn","year":"2006","unstructured":"Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107(6):1219\u201326.","journal-title":"Cancer."},{"key":"40_CR37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(11)70363-1","volume":"9","author":"F Amant","year":"2012","unstructured":"Amant F, Van Calsteren K, Halaska MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012;9:256\u201364.","journal-title":"Lancet Oncol."},{"issue":"5","key":"40_CR38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.earlhumdev.2011.09.001","volume":"88","author":"B Voigt","year":"2012","unstructured":"Voigt B, Pietz J, Pauen S, et al. Cognitive development in very vs. moderately to late preterm and full-term children: can effortful control account for group differences in toddlerhood? Early Hum Dev. 2012;88(5):307\u201313.","journal-title":"Early Hum Dev."},{"issue":"1","key":"40_CR39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1542\/peds.2008-2315","volume":"124","author":"AL Baar van","year":"2009","unstructured":"van Baar AL, Vermaas J, Knots E, et al. Functioning at school age of moderately preterm children born at 32 to 36 weeks\u2019 gestational age. Pediatrics. 2009;124(1):251\u20137.","journal-title":"Pediatrics."},{"issue":"1\u20132","key":"40_CR40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-3782(02)00075-0","volume":"70","author":"EJ Mulder","year":"2002","unstructured":"Mulder EJ, Robles de Medina PG, Huizink AC, et al. Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Hum Dev. 2002;70(1\u20132):3\u201314.","journal-title":"Early Hum Dev."},{"issue":"1","key":"40_CR41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1203\/01.pdr.0000191143.75673.52","volume":"59","author":"BR Bergh Van den","year":"2006","unstructured":"Van den Bergh BR, Mennes M, Stevens V, et al. ADHD deficit as measured in adolescent boys with a continuous performance task is related to antenatal maternal anxiety. Pediatr Res. 2006;59(1):78\u201382.","journal-title":"Pediatr Res."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0040-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-013-0040-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0040-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T20:04:50Z","timestamp":1596139490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-013-0040-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s40272-013-0040-6","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]}}}